U.S. Electrical Stock News

UroGen Pharma (URGN) opened 2026 with Q1 revenue of US$51.0 million and a basic EPS loss of US$0.47, alongside a net income loss of US$23.6 million, setting a clear marker for how the business is scaling while remaining loss making. The company has seen quarterly revenue move from US$20.3 million in Q1 2025 to US$51.0 million in Q1 2026, while basic EPS over that span ranged from a loss of US$1.05 in Q2 2025 to a loss of US$0.47 in the latest quarter. As a result, investors are getting a...

Q1 2026 results snapshot Recursion Pharmaceuticals (RXRX) has kicked off Q1 2026 with revenue of US$6.5 million, basic EPS of US$0.22 loss, and trailing twelve month revenue of US$66.4 million against a trailing net loss of US$559.8 million. Over recent quarters, the company has seen revenue move between US$4.5 million and US$35.5 million, while quarterly basic EPS has ranged from a loss of US$0.20 to a loss of US$0.53 as the business continues to invest heavily and run at sizable losses,...

Solid Power (SLDP) has released its Q1 2026 numbers, with revenue at US$2.1 million and a basic EPS loss of US$0.06, setting the stage for another quarter where the income statement is firmly in the red. The company has seen quarterly revenue move from US$6.0 million in Q1 2025 to US$2.1 million in Q1 2026, while basic EPS has shifted from a loss of US$0.08 to a loss of US$0.06 over the same period, giving investors a mixed read on the top line and per share performance. With consensus still...

Loma Negra Compañía Industrial Argentina Sociedad Anónima (NYSE:LOMA) opened 2026 with Q1 results that put revenue at about ARS 218.7b and basic EPS at ARS 351.37, setting a clear marker for how the year is starting to shape up. Over the past few quarters, the company has seen revenue move from about ARS 279.4b in Q4 2024 to ARS 172.9b in Q1 2025 and then to ARS 270.6b in Q4 2025. Basic EPS shifted from ARS 360.89 to ARS 195.07 and then to ARS 64.39, so this latest print lands against a...

BioCryst Pharmaceuticals (BCRX) opened 2026 with Q1 revenue of US$156.4 million and a basic EPS loss of US$2.98, compared with Q1 2025 revenue of US$145.5 million and essentially breakeven EPS of US$0.00. Over the same period, trailing 12 month EPS shifted from a profit of US$1.26 to a loss of US$2.10. Over the past year, revenue on a trailing 12 month basis moved from US$503.5 million to US$885.7 million, while net income moved from a profit of US$263.9 million in 2025 Q4 to a loss of...

Northwest Natural Holding (NWN) has kicked off Q1 2026 with revenue of US$490.4 million and basic EPS of US$2.33, against trailing 12 month revenue of US$1.3 billion and EPS of about US$2.98, alongside earnings growth of 19.4% over the past year. The company has seen quarterly revenue range from US$164.7 million to US$494.3 million over the last five reported periods, with basic EPS moving between a loss of US$0.73 and a high of roughly US$2.33. This sets up Q1 as a period where the margin...

Kennametal (KMT) Q3 2026 earnings snapshot Kennametal (KMT) has reported Q3 2026 revenue of US$592.6 million and basic EPS of US$0.76 on net income of US$58.2 million, alongside 14.6% earnings growth and a net profit margin that improved to 5.4% over the past year. The company’s revenue increased from US$482.1 million in Q2 2025 to US$529.5 million in Q2 2026 and then to US$592.6 million in the latest quarter. Over the same period, quarterly EPS rose from US$0.23 to US$0.44 and then to...

EyePoint Pharmaceuticals (EYPT) opened 2026 with Q1 revenue of US$0.7 million, a basic EPS loss of US$0.99 per share and a net income loss of US$84.8 million, setting a clear tone for how profitability is tracking into the new year. The company has seen quarterly revenue move from US$24.5 million in Q1 2025 to US$0.7 million in Q1 2026, while quarterly basic EPS shifted from a loss of US$0.65 to a loss of US$0.99. The latest print keeps the focus squarely on how much cash the business is...

Par Pacific Holdings (PARR) Q1 2026 earnings snapshot Par Pacific Holdings (PARR) opened 2026 with Q1 revenue of $1.8 billion and basic EPS of $1.12, providing a clear view of how the business is currently earning its way after a period of volatility. Over the last six quarters, revenue has moved between $1.7 billion and $2.0 billion, while quarterly basic EPS has ranged from a loss of $0.57 to a high of $5.29. This gives investors a wide spectrum of earnings outcomes to consider. With...

Federal Agricultural Mortgage (AGM) is coming off Q1 2026 with total revenue of US$104.1 million and basic EPS of US$4.78, setting the tone for a results season where profitability remains central to the story. The company reported quarterly revenue of US$91.1 million in Q1 2025 and US$104.1 million in Q1 2026, with basic EPS moving from US$4.04 to US$4.78 over the same period. This provides a clear view of how the top line and per share earnings have progressed into this quarter. With...

Shoals Technologies Group Q1 2026 results in focus Shoals Technologies Group (SHLS) opened 2026 with Q1 revenue of US$140.6 million and a small net loss of US$0.3 million, translating to basic EPS of roughly break even at US$0.00. The company has seen quarterly revenue move from US$80.4 million in Q1 2025 to US$140.6 million in Q1 2026, while basic EPS shifted from US$0.00 a year ago to roughly flat again this quarter after positive readings through the intervening quarters. This sets up a...

Rapid7 Q1 2026: Revenue Holds Steady While EPS Softens Rapid7 (RPD) opened 2026 with Q1 revenue of US$209.7 million and basic EPS of US$0.02, alongside trailing twelve month revenue of US$859.2 million and EPS of US$0.34 that frame the latest quarter against a fuller run rate. The company has seen quarterly revenue fluctuate in a tight band between US$209.7 million and US$217.9 million since Q1 2025, while basic EPS has moved from US$0.03 to a peak of US$0.15 in Q3 2025 before landing at...

Q1 2026 results set the stage Community Healthcare Trust (CHCT) opened Q1 2026 with total revenue of US$31.5 million, basic EPS of US$0.07, and net income of US$1.8 million, while FFO reached US$13.4 million, putting the focus firmly on cash generation from its healthcare properties. Over recent quarters the company has seen revenue move from US$29.3 million in Q4 2024 to between about US$30.1 million and US$31.5 million across 2025 and into Q1 2026. EPS has ranged from a loss of US$0.50 to a...

REX Shares and Tuttle Capital Management have launched the T-REX 2X Long AXTI Daily Target ETF, offering 2x daily long exposure to AXT, Inc. The ETF, trading under the ticker AXTU, is designed to magnify the daily performance of NasdaqGS:AXTI for traders who want leveraged access. This fund introduces a new way to trade AXTI’s share moves without using margin or options. NasdaqGS:AXTI, recently trading around $104.83, has drawn strong attention, with the stock posting a 47.5% return over...

Q1 2026: Revenue Holds Steady While Profitability Remains Tight Strata Critical Medical (SRTA) opened 2026 with Q1 revenue of US$67.4 million and basic EPS of US$0.03, alongside net income from ongoing operations of US$2.4 million. This set a mixed tone for the latest update. The company has seen quarterly revenue move from US$36.4 million in Q4 2024 to US$67.4 million in Q1 2026. Basic EPS has ranged from a loss of US$0.09 in Q4 2024 to a profit of US$0.03 in the latest quarter, highlighting...

In late April 2026, FirstCash Holdings reported first-quarter 2026 results showing higher revenue of US$1,051.65 million and net income of US$107.7 million versus the prior year, while also declaring a US$0.42 per share second-quarter dividend and completing a US$50 million share repurchase begun in October 2025. On April 27, 2026, its subsidiary FirstCash, Inc. also moved to issue US$600 million of unsecured senior notes due 2034 in a private placement, aiming to refinance credit facility...

Investors may be considering whether Herbalife at around US$16.44 is still priced attractively or if much of the opportunity has already been reflected in the stock. The share price performance has been strong recently, with returns of 2.9% over 7 days, 15.2% over 30 days, 28.2% year to date and 142.1% over the past year, compared with 19.7% over 3 years and a 66.4% decline over 5 years. Recent coverage has focused on Herbalife's position in the personal products sector, ongoing attention on...

Workiva (WK) opened 2026 with Q1 revenue of US$247.3 million and basic EPS of US$0.33, alongside net income of US$19.0 million, putting fresh numbers behind a stock currently trading at US$51.53. The company reported quarterly revenue of US$206.3 million in Q1 2025 and US$247.3 million in Q1 2026, while basic EPS moved from a loss of US$0.38 to a profit of US$0.33 over the same period, with trailing twelve month EPS at US$0.25 on revenue of US$925.6 million. Margins are clearly in focus here,...

Criteo (CRTO) has opened Q1 2026 with revenue of US$424.6 million and basic EPS of US$0.16, with the latest quarter sitting against a trailing twelve month EPS of US$2.20 on revenue of about US$1.9 billion. Over recent quarters the company has seen revenue move from US$451.4 million in Q1 2025 to US$541.1 million in Q4 2025 and EPS range between US$0.40 and US$0.91, giving investors a clear view of how top line and per share earnings have tracked into this latest print. With net profit...

HNI Q1 2026 earnings snapshot HNI (HNI) has reported Q1 2026 results with revenue of US$1.3 billion and a basic EPS loss of US$0.54, as net income excluding extra items came in at a loss of US$38.8 million. Over the past year, the company has seen trailing twelve month revenue move from US$2.8 billion to US$3.6 billion, while trailing EPS shifted from US$1.13 to US$0.03 as net income excluding extra items moved from US$54.2 million to US$1.5 million. For investors, the mix of higher recent...

CDW (CDW) opened 2026 with Q1 revenue of US$5.7b and basic EPS of US$1.82, setting the tone for how the rest of the year might shape up against investor expectations for growth and profitability. The company reported quarterly revenue of US$5.2b in Q1 2025 and US$5.7b in Q1 2026, while basic EPS increased from US$1.70 to US$1.82 over the same period, giving a clear sense of how the top and bottom lines are tracking year over year. With trailing 12 month net margin easing to 4.7% from 5.1% in...

Q1 2026 earnings snapshot Myriad Genetics (MYGN) reported Q1 2026 revenue of US$200.4 million with a basic EPS loss of US$0.36, setting the tone for another quarter where the focus is firmly on profitability rather than top line scale. Over the past year, the company has seen quarterly revenue move within a tight band from US$195.9 million in Q1 2025 to US$213.1 million in Q2 2025, while basic EPS has ranged from a small loss of roughly US$0.00 in Q1 2025 to a loss of US$3.57 in Q2 2025. With...

NACCO Industries (NC) opened 2026 with Q1 revenue of US$62.8 million and basic EPS of US$1.18, setting a clear marker against a share price of US$50.74. Over recent quarters, the company has reported revenue of US$65.6 million in Q1 2025, US$70.4 million in Q4 2024 and US$62.8 million in Q1 2026, while quarterly EPS moved from US$0.67 in Q1 2025 to US$1.04 in Q4 2024 and US$1.18 in Q1 2026. This sequence gives investors a clearer view of how revenue and earnings are tracking through the...

Everus Construction Group (ECG) Q1 2026 earnings snapshot Everus Construction Group (ECG) opened 2026 with Q1 revenue of US$1.0b and basic EPS of US$1.14, while trailing twelve month EPS reached US$4.38 on revenue of US$4.0b and net income of US$223.4 million, setting a clear baseline for investors tracking profitability. The company has seen quarterly revenue move from US$826.6 million and EPS of US$0.72 in Q1 2025 to US$1.0b and EPS of US$1.14 in Q1 2026, alongside trailing net margin...